Clinical Practice Guideline: The Diagnosis, Treatment, and Follow-Up Management of Thrombotic Thrombocytopenic Purpura

Background

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy. The global incidence of immune-mediated TTP (iTTP) is 1-6 cases per million people per year. The new (S3-level) clinical practice guideline is the first in the German-speaking world to compile evidence- and consensus-based recommendations on the diagnosis, treatment, follow-up management, and care of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) and congenital thrombotic thrombocytopenic purpura (cTTP).